Would there be any potential for them to enhance/partner with CAR-T therapies?

OK, please do tell some resources for #7. Also, how does #1 work?

I follow Cardinal Health, which also has a 'baby boomer' aspect, and was sobered to see an analyst recently say "the market is expecting almost no profit growth over the remainder of the company's life." I think the healthcare conundrum is going to tamp down everything except biotech.

You research your donors so that you can identify the kind of person who is likely to donate.

What an interesting idea, and seems affordable for nonprofits. I am going to share this with some NPO exec directors I know....

Interesting article. But it misses the fact that there has been a lot of share dilution, and the fact they have cut the dividend 8 times in recent years. Marc Lichtenfeld had a good article about it recently here www.talkmarkets.com/.../this-125-dividend-yield-is-too-damn-high

I wouldn't follow someone who has a business relationship with the company they write about - if there were any negatives, how could you mention them?

What 'community' are you referring to, Andreas? Is there somewhere specific I can go to see what they are saying? Or is this from your own reading?

Bill, I looked on your site too, but there is still something wrong with the chart - the headings don't line up so I'm having trouble following it.

You seem to miss the fact that Vuzix makes accessories, it doesn't make augmented reality. You cite Barron's, but what Barron's says is that Vuzix has the best STYLE.